The high frequent germline mutation in GAB2 was also present in acute myeloid leukemia in the International Cancer Genome Consortium study and in acute lymphoblastic leukemia with Ras-independent leukemogenic effects [49]. This evidence concerns the gene GAB2 and acute lymphoblastic leukemia.